The research identifies two promising molecular targets for drug development in breast cancer and metastatic cancer.

Published Date: 29 Mar 2023

NRG Oncology GOG-0240 is a Phase 3 randomized trial that has shown that combining bevacizumab with chemotherapy results in good outcomes and health benefits in women.

Read Full News

Latest News

Estrogen-Only Menopausal HT Linked to Lower Alzheimer’s Risk

Estrogen-only menopausal hormone therapy is linked to lower odds of Alzheimer’s disease pathology and dementia in a large observational study.

Rethink TMP-SMX for Postmenopausal UTIs

Trimethoprim-sulfamethoxazole is associated with more risk for treatment failure than nitrofurantoin in menopausal women with urinary tract infections.

It May Be the Father’s Health Driving Childhood Obesity

Child obesity has a paternal component, offering important clinical opportunities for interventions.

Normalize Patient Conversations About HIV, ACOG Advises

Ob/gyns are uniquely positioned to help reduce disparities in HIV care.

Are Overinvolved Parents Delaying Young Adult Care?

Limited experience of young adults with healthcare and health decisions may increase risks for adult health issues.

Drinking While Pregnant On the Rise

The findings underscore the need for continued alcohol screening and counseling during prenatal care.

Todays Updates

Hyponatremia Risk Varies Among Second-Gen Antipsychotics

Aripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.

HCT Survival Outcomes Improving in Relapsed Hodgkin Lymphoma

Researchers evaluate changes in post-transplantation outcomes among patients with relapsed or refractory Hodgkin lymphoma from 2010 to 2022.

How Much of a Cancer Drug Is Too Much?

In a recent KFF survey, 43% of US adults said they had skipped their medication in the past year because of cost.

Todays Updates

Hyponatremia Risk Varies Among Second-Gen Antipsychotics

Aripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.

HCT Survival Outcomes Improving in Relapsed Hodgkin Lymphoma

Researchers evaluate changes in post-transplantation outcomes among patients with relapsed or refractory Hodgkin lymphoma from 2010 to 2022.

How Much of a Cancer Drug Is Too Much?

In a recent KFF survey, 43% of US adults said they had skipped their medication in the past year because of cost.

Latest News

Estrogen-only menopausal hormone therapy is linked to lower odds of Alzheimer’s disease pathology and dementia in a large observational study.

Trimethoprim-sulfamethoxazole is associated with more risk for treatment failure than nitrofurantoin in menopausal women with urinary tract infections.

Child obesity has a paternal component, offering important clinical opportunities for interventions.

Ob/gyns are uniquely positioned to help reduce disparities in HIV care.

Limited experience of young adults with healthcare and health decisions may increase risks for adult health issues.

The findings underscore the need for continued alcohol screening and counseling during prenatal care.

News All Time

Miscarriage Care Model Helps Identify Modifiable Risk Sooner

A UK model finds a surprising top modifiable risk factor; patient and staff satisfaction with the model of care is high.

Lack of Menopause Care in Canada Reflects Systemic Issues

A dearth of primary care providers and critical lack of education among healthcare workers on how to manage menopause leave Canadian women without help.

Sexual Dysfunction Persists With Endometriosis Postpartum

Potential long-term sexual dysfunction and quality of life are often overlooked after the disease is treated and the patient gives birth.

Risk Stratification for HR+/HER2- Early-Stage Breast Cancer: Insights Into Clinical and Genomic Risk Evaluations

Risk Stratification for HR+/HER2- Early-Stage Breast Cancer: Insights Into Clinical and Genomic Risk Evaluations

Why Does This Pregnant Woman Have Rectal Bleeding?

Getting a diagnosis was crucial, but options were limited for safe investigation

At-Home Transvaginal Ultrasound Feasible, Preferred by Some Patients

Trained remote sonographers guided patients through the process

Hospital Under Investigation; 4,000 Nurses Strike; Fentanyl Makers Pivot to Peptides

Health news and commentary gathered by MedPage Today staff

Medicaid Funding Resumes for Planned Parenthood After Halting for Most of a Year

Some services are returning but others may not

Translating Risk Into Tailored Adjuvant Therapy in Early-Stage HR+/HER2- Breast Cancer

Translating Risk Into Tailored Adjuvant Therapy in Early-Stage HR+/HER2- Breast Cancer

Advancing TNBC Care: Clinical Insights and Effective Application of Emerging Treatment Strategies Across Lines of Therapy

Advancing TNBC Care: Clinical Insights and Effective Application of Emerging Treatment Strategies Across Lines of Therapy

Molecular Matters: Next-Gen Sequencing, Liquid Biopsy, and the Future of ctDNA Applications

Molecular Matters: Next-Gen Sequencing, Liquid Biopsy, and the Future of ctDNA Applications

Rewiring Resistance: Precision Sequencing and Mechanism-Driven Care in Platinum-Resistant Ovarian Cancer

Rewiring Resistance: Precision Sequencing and Mechanism-Driven Care in Platinum-Resistant Ovarian Cancer

What Vitamin K Shot Refusals Are Really Telling Us

We can't fact-check our way out of a trust crisis

Maternal RSV Vaccine Linked to Lower Risk of Infant Hospitalization

"This is real protection, and it really applies to all comers," researcher says

Genomic Test May Spare More Patients With Node-Positive Breast Cancer From Chemo

Experts discuss Prosigna-guided treatment decisions in high-risk early disease

Optimizing Perioperative Therapy in Triple-Negative Breast Cancer

The treatment landscape for these patients is evolving

Recommended News For You

Is Laughter Good for Blood Glucose Control?

Increased anti-tumor response and reduced side effects from immune checkpoint inhibitors.

Researchers can now forecast how prostate cancer bone metastases will react to radium-223 treatment.

How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace

Smarter targeted radiotherapy just as effective for low-risk breast cancer and reduces risk of side effects

Glioblastoma treatment breakthrough shows promise

In advanced endometrial cancer, immunocheckpoint inhibitor-chemotherapy combination improves overall survival.

Recommended Articles For You

The Latest Advances in Glioblastoma Treatment and Prevention  

A Closer Look at MCV Modules: Features, Functions, and Benefits  

The importance of understanding normal serum osmolality 

Unlocking the Potential of Hemin: A Novel Approach to Health and Wellbeing 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Psychedelic Therapy Tied to Reduced Depression, Anxiety.

2.

Frontline EGFR/VEGF Inhibition Slows Advanced EGFR-Positive Lung Cancer

3.

Taking vitamin D daily decreased cancer mortality, according to a study.

4.

Study reveals increase in late-stage breast cancer diagnoses in US

5.

Prostate cancer Q&A: Improving detection and reducing overtreatment

1.

Virtual Survivorship Platforms in Cancer Care: Transforming Post-Treatment Support and Outcomes

2.

Unlocking the Potential of Talquetamab: A Revolutionary Approach to Cancer Treatment

3.

Emerging Therapies and Technologies Reshaping Oncology: Innovations and Impact in 2025

4.

The Importance of Understanding Your D-Dimer Levels: A Comprehensive Guide

5.

Women's Cancer Survivorship: Emerging Long-Term Health Priorities

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII

3.

Expert Perspectives on Hematology

4.

Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment

5.

Navigating the Complexities of Ph Negative ALL - Part VIII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot